Skip to main content
PROVEXIS PLC logo

PROVEXIS PLC — Investor Relations & Filings

Ticker · PXS ISIN · GB00B0923P27 LEI · 21380042E3Y3N9VZ6N48 IL Professional, scientific and technical activities
Open in API
Filings indexed 207 across all filing types
Latest filing 2023-12-29 Earnings Release
Country GB United Kingdom
Listing IL PXS

About PROVEXIS PLC

https://www.provexis.org/

Provexis PLC is a life sciences company that develops, licenses, and commercializes functional ingredients for the global food, beverage, and dietary supplement markets. The company's principal technology is Fruitflow®, a patented, scientifically-proven bioactive ingredient derived from tomatoes. Fruitflow® is designed to support cardiovascular health by helping to maintain normal blood platelet aggregation, which contributes to healthy blood flow. Provexis licenses its technology to business partners for inclusion in their consumer products.

Recent filings

Filing Released Lang Actions
Half-year Report
Earnings Release Classification · 100% confidence The document is titled 'UNAUDITED INTERIM RESULTS FOR SIX MONTHS TO 30 SEPTEMBER 2023' and provides detailed financial highlights (revenue, sales figures) and operational updates for a six-month period. This structure—unaudited results for a period shorter than a year—is characteristic of an Interim or Quarterly Report. The RNS Number suggests it was released via a regulatory news service, but the content itself is the comprehensive financial report for the period, not just an announcement of its publication. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-12-29 English
Result of AGM
AGM Information Classification · 100% confidence The document explicitly states 'Result of AGM' and details the voting results for various resolutions presented at the 'Company's Annual General Meeting, held earlier today'. This content directly relates to the proceedings and outcomes of an Annual General Meeting. The filing type code AGM-R (AGM Information) is the most appropriate classification.
2023-10-26 English
Group of companies' accounts made up to 2023-03-31
Regulatory Filings
2023-10-13 English
Final Results
Earnings Release Classification · 99% confidence The document explicitly states: 'PRELIMINARY RESULTS for the YEAR ended 31 MARCH 2023' and provides detailed financial figures, including 'Total revenue for the year £390k' and 'Underlying operating loss* £348k (2022: £173k)'. This content is characteristic of a comprehensive annual financial report summary. Although it mentions the 'Annual report and accounts and notice of AGM' will be available later, the provided text itself contains the core financial results for the full fiscal year ended March 31, 2023. This aligns best with the Annual Report (10-K) definition, which covers full company activity and financial performance, even if this specific document is the preliminary release preceding the final filing. FY 2023
2023-09-29 English
BYHEALTH regulatory filing with Chinese SAMR
Regulatory Filings Classification · 100% confidence The document is identified by the 'RNS Number : 7831K' header and concludes with standard RNS boilerplate text, indicating it is a regulatory news service announcement from the London Stock Exchange. The content details an update regarding a partner company (BYHEALTH) filing for a new health function claim with the Chinese regulatory body (SAMR) for the Fruitflow ingredient. This type of announcement, which is a specific operational/regulatory update that doesn't fit neatly into financial reports (10-K, IR), earnings releases (ER), or director dealings (DIRS), is best classified as a general Regulatory Filing (RNS). It is not a full report, nor is it a specific announcement like a dividend or management change.
2023-08-30 English
Capital structure and funding update
Capital/Financing Update Classification · 98% confidence The document is identified by the RNS Number (0513V) and the header 'National Storage Mechanism', indicating it is a regulatory announcement distributed via the London Stock Exchange's RNS service. The content discusses the company's 'Capital structure and funding update,' specifically detailing the transfer of customers from DSM, inventory management, and the expectation that the Group will need to raise further equity or loan finance in the coming months. This discussion about financing needs and capital structure changes strongly aligns with the definition of a Capital/Financing Update (CAP). Although it is distributed via RNS, the core subject matter is financing, making CAP more specific than the general RNS fallback.
2023-04-03 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.